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Abstract
 
Contact hypersensitivity (CHS) is thought to be mainly associated with the activation of T
helper type 1 (Th1) cells. However, there is also evidence that Th2 cells or Th2 cytokines play
a role in the development of CHS. To analyze the functional contribution of Th2 cytokines in-
terleukin (IL)-4 and IL-13, signal transducer and activator of transcription 6 (STAT6)-deficient
 
(STAT6
 
2
 
/
 
2
 
) and wild-type (wt) control C57BL/6 mice were contact sensitized with 5% 2,4,6-
trinitrochlorobenzene (TNCB), 0.5% 2,4-dinitrofluorobenzene, or 5% 4-ethoxyl methylene-2-
phenyl-2-oxazolin-5-one, and any skin reactions were examined. Ear swelling was significantly
reduced with a delayed peak response in STAT6
 
2
 
/
 
2
 
 mice compared with wt mice.
A histological analysis revealed that the infiltration of both eosinophils and neutrophils in the
skin challenged after 24 h in STAT6
 
2
 
/
 
2
 
 mice decreased substantially compared with that in wt
mice. The expression of Th2 cytokines (IL-4, IL-5) in TNCB-challenged skin tissues and the
supernatants from T cells stimulated by 2,4,6-trinitrobenzene sulfonate–modified spleen cells, as
well as the immunoglobulin (Ig)E and IgG1 response after challenge, were also profoundly re-
 
duced in STAT6
 
2
 
/
 
2
 
 mice, whereas the expression of interferon 
 
g
 
 was the same in STAT6
 
2
 
/
 
2
 
and wt mice after challenge. Furthermore, adoptive transfer experiments revealed that STAT6
 
2
 
/
 
2
 
mice induced CHS after injection of lymph node cells obtained from sensitized wt mice. Our
data suggest that the STAT6 signal plays a critical role in the induction phase of CHS.
Key words: signal transducer and activator of transcription factor 6 • contact hypersensitivity • 
Th2 • IL-4 • IL-13
 
Introduction
 
Contact hypersensitivity (CHS)
 
1
 
 is thought to be associated
with the activation of T cells of Th1 type. However, the
role of Th2 cells in CHS is still not clear. Gocinsli and
Tigelaar (1) demonstrated that both CD4
 
1
 
 and CD8
 
1
 
 T
cells play a role in inducing CHS, and also that an addi-
tional subset of CD4
 
1
 
 T cells plays a downregulatory role.
It has also been demonstrated that in IL-4/IL-10–secreting
CD4
 
1
 
 T cells, Th2 negatively regulates CHS response (2).
Steinbrink et al. (3) implicated a downregulatory role of
CD8
 
1
 
 T cells producing IL-4, IL-5, and IL-10.
A negative regulatory effect of IL-4 on the CHS re-
sponses to 2,4,6-trinitrochlorobenzene (TNCB) was re-
ported by Gautam et al. (4) and Asada et al. (5). These au-
thors observed that IL-4 inhibited the efferent phase of
CHS, but not the afferent phase (4, 5). Furthermore, we
also recently demonstrated that IL-4 blocked CHS by the
inhibition of Langerhans cell (LC) migration induced by
TNF-
 
a
 
 (6).
Contrary to these reports, IL-4 has been demonstrated
by several groups to be an essential cytokine during the
elicitation phase of CHS (7–9). Recently, it has been re-
ported that the CHS response was diminished in IL-4–defi-
cient mice at a late phase of the elicitation reaction (10). In
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Abbreviations used in this paper:
 
 CHS, contact hypersensitivity; DEC,
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persensitivity; EC, epidermal cell; LC, Langerhans cell; STAT, signal
transducer and activator of transcription; TNBS, 2,4,6-trinitrobenzene
sulfonate; TNCB, 2,4,6-trinitrochlorobenzene; wt, wild-type. 
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contrast to these recent findings, Berg et al. (11) reported
that there is no alteration in the CHS response induced by
4-ethoxyl methylene-2-phenyl-2-oxazolin-5-one (Oxa) in
IL-4–deficient mice. Therefore, it remains to be clarified
whether or not CHS is diminished in IL-4–deficient mice.
Recently, Traidl et al. (12) reported that the complete loss
of endogeneous IL-4 expression in Balb/c mice is associ-
ated with an impaired manifestation of CHS to dinitro-
chlorobenzene but not to Oxa (12). We also recently es-
tablished signal transducer and activator of transcription
factor 6 (STAT6)-deficient (STAT6
 
2
 
/
 
2
 
) mice (13) and
demonstrated that STAT6 plays a central role in IL-4– and
IL-13– mediated biological responses (13, 14). In an at-
tempt to clarify the role of Th2 cytokines, especially IL-4
and IL-13 in the CHS response, we examined the CHS re-
sponse in the STAT6
 
2
 
/
 
2
 
 mice in which the IL-4 and IL-13
signaling pathways have been completely abolished.
 
Materials and Methods
 
Animals.
 
C57BL/6 mice with a targeted disruption of the gene
encoding STAT6 (Stat6
 
2
 
/
 
2
 
) were generated in the Department of
Biochemistry at the Hyogo College of Medicine as previously re-
ported (13), and age- and sex-matched wild-type (wt) littermate
controls (C57BL/6 mice) were purchased from the Sankyo Co. All
animals were housed under specific pathogen-free conditions and
had free access to a commercial diet and water. They were used at
8–15 wk of age. Each experimental group consisted of at least five
mice.
 
Reagents.
 
The following reagents were obtained from com-
mercial sources: TNCB and Hepes from the Nakarai Chemical
Co.; 2,4-dinitrofluorobenzene (DNFB), Oxa from the Sigma
Chemical Co.; and trypsin, 1:250 from Difco. The following
mAbs were used: FITC-conjugated anti–TCR-
 
a
 
/
 
b
 
 mAb (ham-
ster; PharMingen); PE–conjugated anti–TCR-
 
g
 
/
 
d
 
 mAb (hamster;
PharMingen); FITC-conjugated anti–TCR-
 
g
 
/
 
d 
 
mAb (hamster;
PharMingen); FITC-conjugated anti-Thy1.2 (IgG2; Caltag); PE-
conjugated anti-Ly2 (hamster; PharMingen); PE-conjugated anti–
mouse CD4 (L3T4) mAb (PharMingen); FITC-conjugated anti–
mouse I-A
 
b
 
 (mouse; Cedarlane); PE-conjugated anti–mouse CD80
mAb (hamster; PharMingen); PE-conjugated anti–mouse CD86
mAb (hamster; PharMingen); PE-conjugated anti–mouse CD11b
(rat, Mac-1a; Leinco Technologies); PE-conjugated anti–mouse
F4/80 mAb (Cedarlane); PE-conjugated anti–mouse CD32/16
mAb (rat, clone 93; Southern Biotechnology Associates); PE-con-
jugated anti–mouse V
 
g
 
3 TCR mAb (hamster; PharMingen); anti–
mouse IL-4Ra (S-20) mAb (rabbit; Santa Cruz Biotechnology);
and PE-conjugated anti–rabbit IgG(H
 
1
 
L) mAb (Cedarlane).
 
Immunization for Induction of CHS to TNCB, DNFB, and Oxa.
 
The mice were contact sensitized by two daily consecutive topical
applications of 50 
 
m
 
l of 0.5% solution of DNFB, 5% TNCB, or 3%
Oxa in acetone in olive oil (4:1) on shaved abdominal skin. The
control mice were treated in the same fashion with vehicle alone.
 
Challenge and Quantitation.
 
3 d after the last abdominal applica-
tion, the mice were challenged by applying 20 
 
m
 
l of hapten solu-
tion (1% TNCB, 0.2% DNFB, 0.5% Oxa in olive oil) on both
sides of one ear, and vehicle on both sides of the other ear. The
thickness of the ear was then measured with an engineer’s mi-
crometer (Peacock; Ozaki Engineering) at 12, 24, 48, 72, and 96 h
after challenge.
 
Induction of Irritant Response and Delayed Hypersensitivity Induced
by Sheep RBCs.
 
The irritant response was induced by applying
10 
 
m
 
l of 1 or 100% croton oil (vol/vol) to the dorsal and ventral
aspects of the right ear of Wt and STAT6
 
2
 
/
 
2
 
 mice. The reaction
was then evaluated by measuring the increase in ear thickness
over time. wt and STAT 6
 
2
 
/
 
2
 
 mice were sensitized with a sub-
cutaneous injection of 100 
 
m
 
l of 20% sheep RBCs in the back. 6 d
after sensitization, the mice were challenged by the injection of
20 
 
m
 
l of 20% sheep RBCs in the foot pad. The increases in foot
pad thickness of wt or STAT 6
 
2
 
/
 
2
 
 mice were measured with an
engineer’s micrometer at 24 and 48 h after the challenge.
 
Preparation of Enriched LCs.
 
The procedure for isolating basal
epidermal cells (ECs) from the epidermis was described previ-
ously (15). In brief, separated pinnae were cut into 3- or 4-mm
 
2
 
pieces, then transferred dermal side down into a Petri dish. After
a 1-h incubation at 37
 
8
 
C in PBS containing 0.5% trypsin
(Difco), epidermal sheets were peeled from the dermis using for-
ceps and placed in “complete medium” (RPMI 1640 containing
10% heat-inactivated FCS, 2 mM 
 
l
 
-glutamine, 50 mg/ml genta-
mycin, and 100 U/ml penicillin) supplemented with 0.0025%
DNase I (Sigma Chemical Co.) After 20–30 min at room tem-
perature, the sheets were vigorously stirred, and the resulting cell
suspension was pelleted and resuspended in ice-cold, hypoosmo-
lar PBS using simultaneous light-speed vortexing. This proce-
dure was terminated by adding an excessive amount of washing
medium when the viability of the cell suspension had dropped to
a level of 10–20%. After two washes, 5 ml of the EC suspension
(5 
 
3 
 
10
 
6
 
/ml) was layered on top of 5 ml of Lympholyte-M solu-
tion (density 1.0875; Cedarlane) and centrifuged at 1,500 
 
g
 
 for
20 min at room temperature. Thereafter, the cells were collected
from the interface and rinsed twice in complete medium, then
cultured for 24 h, counted, tested for viability, and subjected to
FITC-conjugated anti–I-A
 
b
 
 immunolabeling (see below). The
enrichment of LCs was usually 23–46%.
 
Immunofluorescence Analysis of Cell Suspension.
 
EC suspen-
sions enriched for LCs as described above were cultured for 24 h
in complete medium with 100 ng/ml GM-CSF (Genzyme) in
24-well plate wells (no. 258201; Corning) at 37
 
8
 
C under 5%
CO
 
2
 
 air. The ECs were then rinsed in ice-cold PBS containing
0.1% NaN
 
3
 
 with 1% FCS, and incubated for 30 min with 2.5
 
m
 
g/ml of the FITC-conjugated anti–I-A
 
b 
 
mAb or the appropri-
ate FITC-labeled IgG1 control. After a short exposure to normal
mouse serum, ECs were incubated with either PE-conjugated
anti-CD11b mAb, PE-conjugated anti-F4/80 mAb, PE-conju-
gated anti-CD32 mAb, PE-conjugated anti-CD80 mAb, or PE-
labeled anti-CD86 mAb or the appropriate isotype control (PE–
mouse IgG1, 5 mg/ml; Becton Dickinson). Flow cytometry was
performed with a FACS
 
®
 
 analyzer (Cyto ACE-150; Jasco Ltd.),
using 10,000 cells per sample. Any dead cells were gated out
with ethidium bromide.
To compare the surface markers of T cells in STAT6
 
2
 
/
 
2
 
 and
wt mice, at 5 d after sensitization with TNCB, the STAT6
 
2
 
/
 
2
 
 or
wt mice were killed by cervical dislocation, and their peripheral
lymph nodes were removed. A cell suspension was then prepared
by gentle teasing, and was thereafter washed three times with
PBS. These cells were passed through a nylon fiber column
(Wako Pure Chemicals), and were used as T cells. The T cells
were rinsed in ice-cold PBS containing 0.1% NaN
 
3 
 
with 1%
FCS, and then incubated for 30 min with 2.5 mg/ml of the
FITC-conjugated anti-CD4 mAb, FITC-conjugated anti–mouse
TCR-
 
a
 
/
 
b
 
 mAb, FITC-conjugated anti-Thy1 mAb, or the ap-
propriate FITC-labeled IgG1 control. After a short exposure to
normal mouse serum, the cells were incubated with either PE- 
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conjugated mAbs or the appropriate isotype control (PE–mouse
IgG1, 5 mg/ml; BD).
Flow cytometry was performed with a fluorescent microscope
(Nikon) or FACS
 
®
 
 analyzer using 10,000 cells per sample. Dead
cells were gated out with ethidium bromide.
 
Phenotypic Analysis and Enumeration of LCs and Thy1 Dendritic
ECs.
 
Ear skin from the mice was placed in 0.5 M ammonium
thiocyanate (0.1 M phosphate buffer, pH 6.8) at 37
 
8
 
C for 20
min. The epidermis was separated from the dermis, fixed with
acetone for 5 min, and then washed extensively with PBS. Epi-
dermal sheets were incubated overnight at 4
 
8
 
C with FITC-con-
jugated anti-Ia
 
b
 
 mAb, FITC-conjugated anti–TCR-
 
g
 
/
 
d
 
 mAb,
or FITC isotype control IgG. After washing three times with
PBS, the sheets were mounted in 1% glycerine in PBS. Posi-
tively stained cells in 
 
.
 
90 randomly chosen fields of epidermis
were counted at a magnification of 400 using a rectangular grid.
More than 500 I-A
 
1
 
 dendritic cells or 
 
g
 
/
 
d
 
1
 
 
 
dendritic cells from
each STAT6
 
2
 
/
 
2
 
 or wt mouse were counted.
 
Primary Allogeneic Mixed EC–Lymphocyte Reaction.
 
T cells
were prepared using a nylon wool column. More than 97% of
nonadherent cells were CD3
 
1
 
 T cells based on immunofluores-
cence tests with directly labeled mAb to CD3. Stimulator cells
consisted of cultured LCs enriched as described above from
Stat6
 
2
 
/
 
2
 
 
 
or wt mice.
1–10
 
3 
 
3 
 
10
 
5
 
 LC-enriched ECs per well were seeded as stimu-
lator cells. Responders and stimulators were cocultured in 96-
well round-bottomed plates at 37
 
8
 
C in 200 
 
m
 
l of complete
medium. All cultures were pulsed overnight with 0.2 
 
m
 
Ci
[
 
3
 
H]TdR, and incorporated radioactivity was assessed by liquid
scintillation counting (16).
 
Quantification of Cytokine Levels in the Supernatant from Cultured
T Cells and in Skin Tissue Extracts.
 
The lymph node cells and
spleen cells were prepared as described above. Single cell suspen-
sions from lymph nodes were purified for T cells by nylon wool
column. The spleen cells were suspended in 1.0 ml of 10 mM
2,4,6-trinitrobenzene sulfonate (TNBS), incubated at 37
 
8
 
C for
10 min, washed three times, and used as stimulator cells. 10
 
5
 
 T
cells were cultured in 96-well round-bottomed plates in 200 
 
m
 
l
of complete medium in the presence or absence of 10
 
5
 
 mitomy-
cin C–treated TNBS-modified spleen cells or nonmodified
spleen cells for 3 d. The supernatants were harvested and store at
 
2
 
80
 
8
 
C. These supernatants were used for ELISA.
Samples of ear tissue extracts for ELISA were prepared as de-
scribed by Ferguson et al. (17). In brief, at 24 h after the applica-
tion of TNCB, the ears were excised and immediately homoge-
nized with a 10-fold vol of 0.1% Tween 20 in PBS. The samples
were quickly frozen in liquid nitrogen, thawed in a 37
 
8
 
C water
bath, sonicated for 15 s, and centrifuged for 5 min at 13,000 
 
g
 
,
and supernatants were used for ELISA. The supernatants were
stored at 
 
2
 
80
 
8
 
C. The ELISA assays for IL-4, IL-5, and IFN-
 
g
were conducted using ELISA kits (Endogen) according to the
manufacturer’s instructions.
Measurement of Serum Concentrations of IgE, IgG1, and IgG2.
Blood was drawn from the sinus cavernous, and serum was ob-
tained by centrifugation at 1,500 g for 10 min. The serum IgE
level was determined using a commercial ELISA kit (Yamasa).
Concentrations of IgG1 and IgG2 were determined using com-
mercial ELISA kits (Bethyl Laboratories) according to the manu-
facturer’s instructions.
Adoptive Transfer Experiments. Cell suspensions obtained from
lymph nodes from TNCB-sensitized wt mice were injected into
the ears of naive STAT62/2 mice or wt mice (five mice per
group; 2 3 105 per 20 ml PBS [12]). The mice were immediately
challenged by applying 10 ml 1% TNCB in olive oil or olive oil
alone on both sides of the ear. In these experiments, negative
controls were groups of mice injected with PBS subcutaneously
into the ear and challenged with 1% TNCB, or groups of mice
injected with lymph node cells subcutaneously into the ear and
challenged with olive oil. Ear thickness was measured as de-
scribed above after 24 h.
Figure 1. STAT62/2 mice exhibit a reduced CHS elicitation. STAT62/2
mice (h, j) and wt (WT) mice (n, m) were contact sensitized for 2 d
with (A) 5% TNCB, (B) 5% Oxa, or (C) 0.5% DNFB 2 d after the last im-
munization, and thereafter both mice were challenged. The maximal ear
swelling was detected at 24 h for the wt mice and at 72 h for the STAT62/2
mice. The data presented are the mean values 1 SD of five mice per group
and are representative of five independent experiments. *P , 0.01, signifi-
cant compared with the results obtained with wt mice.998 STAT6 Signaling in Contact Hypersensitivity
Histological Examination. The ear skin specimens were ex-
cised and fixed in 10% formalin, then processed and stained with
hematoxylin and eosin, May-Grünwald-Giemsa, or toluidine
blue. The number of mononuclear cells, mast cells, and granulo-
cytes such as neutrophils and eosinophils infiltrating into the der-
mis was evaluated by staining the tissue specimen stained with
Giemsa solution. The section was examined at a magnification of
400. At least 10 fields were examined for each lobe. The number
of cells was counted and expressed as the number of cells per
square millimeter.
Statistical Analysis. The experimental data are expressed as
the mean 6 SD and shown in the figures as mean 1 SD for clar-
ity. The statistical analysis was performed using the Student’s t
test.
Results
Diminished CHS Response to DNFB, TNCB, and Oxa in
STAT62/2 Mice. To evaluate the capacity of STAT62/2
mice to develop a CHS reaction, we examined the CHS
response to DNFB, TNCB, and Oxa in STAT62/2 and
wt mice. As shown in Fig. 1, the CHS response to DNFB
decreased drastically, and the early phase of CHS to
TNCB or Oxa was significantly diminished in STAT62/2
mice compared with wt mice (Fig. 1, A–C). The peak re-
sponse of ear swelling was detected 24 h after the chal-
lenge in wt mice, whereas the peak response was observed
at 48 h after challenge in STAT62/2 mice.
Normal Irritation Response and Delayed-Type Hypersensitiv-
ity Response Induced by Sheep RBCs of STAT62/2 Mice.
To determine whether or not STAT6 signaling is also es-
sential for the induction of an irritant response, the irritant
response was examined in STAT62/2 and wt mice after a
challenge with the irritant croton oil. After exposure to 1
or 100% croton oil, maximal swelling was detected at 24 h
in both wt and STAT62/2 mice (Fig. 2 A and B). As with
the irritant treatment, no difference was observed between
the STAT62/2 and wt mice.
The data presented in Fig. 3 show the delayed-type hy-
persensitivity (DTH) response induced by sheep RBCs in
STAT62/2 and wt mice. After the challenge with a subcu-
taneous injection of sheep RBCs, maximal swelling was
detected at 24 h in both wt and STAT62/2 mice. There
was no significant difference between STAT62/2 and wt
mice.
Histopathology of TNCB-induced CHS Induced in STAT62/2
Mice. Since the CHS to TNCB in STAT62/2 mice de-
creased at 24 h after challenge, we performed a histological
analysis in STAT62/2 mice and wt mice sensitized by
TNCB. As shown in Fig. 4, a histological examination re-
vealed that severe edema was detected in the challenged
skin of the wt mice (Fig. 4 A), but not in the STAT62/2
mice (Fig. 4 B). A very severe inflammatory response with
a strong infiltration of eosinophils, neutrophils, and mono-
nuclear cells was observed in wt mice (Fig. 4 C). In con-
trast, only a mild inflammatory response with a diminished
infiltration of mononuclear cells and neutrophils was ob-
served in the challenged skin in STAT62/2 mice (Fig. 4
D). The number of infiltrated mononuclear cells, eosino-
phils, and neutrophils in the skin was calculated in both
the STAT62/2 and wt mice. TNCB-challenged wt mice
had a significantly greater number of eosinophils and neu-
trophils than the TNCB-challenged STAT62/2 mice (P ,
0.01; Fig. 5).
No Elevation of Serum IgE and IgG1 in STAT62/2 Mice
Challenged with TNCB. As IgE is thought to be impor-
tant in the pathogenesis of CHS (18, 19), STAT62/2 and
wt mice sensitized with TNCB were challenged with
TNCB or olive oil. At 24 h after the TNCB-sensitized
mice were challenged, the mice were bled, and the serum
concentrations of IgE, IgG1, and IgG2a were measured by
ELISA. The TNCB-challenged wt mice produced signifi-
cantly higher amounts of serum IgE than the olive oil–
challenged littermates. In contrast, neither the olive oil–
nor the TNCB-challenged STAT62/2 mice produced
Figure 2. The STAT62/2 mice did not ex-
hibit a reduced irritant response. The increases
in the ear thickness of wt (WT) or STAT62/2
mice on a C57BL/6 background were mea-
sured 24 and 48 h after the application of (A)
1% croton oil or (B) 100% croton oil. The
data presented are the mean values 1 SD of
five mice per group and are representative of
three independent experiments.
Figure 3. The STAT62/2 mice did not exhibit a reduced DTH in-
duced by sheep RBCs (SRBC). Wt (WT) and STAT62/2 mice were
sensitized with the subcutaneous injection of 0.1 ml of 20% sheep RBCs.
The increases in foot pad thickness of the wt or STAT62/2 mice on a
C57BL/6 background were measured 24 and 48 h after challenge by 20%
sheep RBCs. Data presented are the mean values 1 SD of five mice per
group and are representative of three independent experiments.999 Yokozeki et al.
detectable levels of serum IgE (Fig. 6). The wt mice dis-
played the expected increase in IgG1 concentration after
TNCB challenge, whereas the serum IgG1 levels were not
augmented after the TNCB challenge (Fig. 7 A). The se-
rum concentration of IgG2a equally but not significantly
increased after the TNCB challenge in both the wt and
STAT62/2 mice, indicating that both mice were sensitized
with TNCB (Fig. 7 B).
Lymph Nodes and Local Production of Cytokines in STAT62/2
Mice. Neither IL-4 nor IL-5 was detected in the super-
natants from T cells stimulated with TNP-conjugated
spleen cells in STAT62/2 mice. However, the level of
IFN-g in the supernatants from T cells of STAT62/2 mice
was comparable to that in the wt mice (Fig. 8 A).
In the supernatant from skin tissue obtained from
TNCB-challenged wt mice, the levels of both IL-4 and
IL-5 were significantly higher than those in the superna-
tant from olive oil–challenged wt mice (Fig. 8 B). In con-
trast, these Th2 cytokine levels in the supernatant from
TNCB-challenged STAT62/2 mice did not increase (Fig.
Figure 4. Histopathological findings
of the CHS induced by TNCB painting
in wt or STAT62/2 mice. Wt mice or
STAT62/2 mice were immunized for
two consecutive days by topical painting
with 5% TNCB. 3 d after the last ab-
dominal application, the mice were
challenged by applying 1% TNCB solu-
tion. Histological features of the 24-h
CHS ear skin reaction challenged by
TNCB in wt mice (A and C) or in
STAT62/2 mice (B and D) stained with
Giemsa solution. An extremely large de-
gree of edema was detected in the
TNCB-challenged skin in the wt mice
(A) but not in the STAT62/2 mice (B).
A strong infiltration of mononuclear
cells (Mo), neutrophils (Neu), and eosin-
ophils (Eo) was observed in the dermis
of wt mice (C); however, a diminished
infiltration of neutrophils and mononu-
clear cells was observed in the dermis of
STAT62/2 mice (D).1000 STAT6 Signaling in Contact Hypersensitivity
8 B). The level of IFN-g in the STAT62/2 mice was
comparable to that in the wt mice (Fig. 8 B).
Cytofluorometric Enumeration of LCs and Thy1 Dendritic
ECs in Epidermal Sheets, and Characterization of Surface
Marker of LCs in Cell Suspension. The CHS response is
dependent on the capacity of LCs of the skin to present
the allergen and to activate T cells. To determine whether
the morphology and distribution of LCs in STAT62/2
mice were normal, epidermal sheets were prepared from
the ears of STAT62/2 and wt mice. The LCs were stained
with anti-Iab mAb. The epidermal sheets obtained from
STAT62/2 mice revealed an equal number of LCs com-
pared with the LCs of wt mice (Fig. 9 A). No difference in
the morphology of LCs was detected in the epidermal
sheet between STAT62/2 and wt mice (data not shown).
Furthermore, we examined the differences in the surface
marker on LCs between wt and STAT62/2 mice by a
FACS® analysis. The expression of CD40, CD80, CD86,
intercellular adhesion molecule 1, CD32, CD11b, and F4/
80 on LCs in STAT62/2 mice was comparable with that
in the wt mice (data not shown).
Assessment of the T Cell–stimulatory Capacity of Epidermal
Cells in STAT62/2 Mice. To investigate whether the LCs
contained within the EC population were capable of sup-
porting T cell stimulation, the ability of LCs to induce
proliferation of allogeneic T cells was determined. The en-
riched LCs were prepared as described in Materials and
Methods. The population of LCs in ECs in STAT62/2
was not substantially different from that in the wt mice in
each experiment. Cultured enriched LCs in STAT62/2
mice provided efficient stimulators of T cell proliferation
when alloreactive Balb/c mouse spleen cells were used as
the responder T cells (Fig. 9 B). These results indicated
that the T cell–stimulatory capacity of enriched LCs in the
skin of STAT62/2 mice was comparable to that in the
control mice (Fig. 9 B).
Lymph Node Cells from Wt Mice Induced CHS in
STAT62/2 Mice. To clarify whether the defect of CHS
in STAT62/2 is at the afferent or efferent phase, adoptive
transfer experiments were conducted. Lymph node cells
from the wt mice sensitized with 5% TNCB were injected
subcutaneously into the ears of STAT62/2 mice or wt
mice, followed by a challenge with TNCB applied epicu-
taneously. Ear swelling was measured 12 and 24 h after
challenge. As expressed in Fig. 10, not only wt but also
STAT62/2 mice exhibited CHS after the injection of
lymph node cells from the sensitized wt mice (Fig. 10).
Figure 5. Effect of STAT6 deficiency on the cellular distribution of
challenged skin. Challenged skin was obtained from wt (WT) and
STAT62/2 mice after challenge with the application of 1% TNCB or ol-
ive oil. Bars represent the number of eosinophils, neutrophils, mono-
cytes/macrophages, and mast cells that infiltrated the challenged skin. The
results shown are from a single experiment representative of three separate
experiments. *P , 0.01 vs. TNCB-challenged wt mice. **P , 0.05 vs.
TNCB-challenged wt mice.
Figure 6. Serum IgE levels of sensitized wt and STAT62/2 mice chal-
lenged with olive oil and TNCB. Mice were treated as described in Ma-
terials and Methods. The serum was analyzed by ELISA. The data repre-
sent the mean 1 SD for groups of four mice and are representative of
three independent experiments. Ig levels were measured by ELISA at 24 h
after the challenge. *P , 0.01 compared with other groups.
Figure 7. The serum IgG1 (A) and IgG2a (B) levels in olive oil– and
TNCB-challenged sensitized wt (WT) and STAT62/2 mice. The mice
were treated as described in Materials and Methods. Serum was analyzed
by ELISA. The data represent the mean 1 SD for groups of four mice
and are representative of three independent experiments. The Ig level
was measured by ELISA at 24 h after the challenge. *P , 0.01 compared
with other groups.1001 Yokozeki et al.
These data thus indicated that STAT6 is an important sig-
nal during the induction of CHS.
Discussion
Although considerable progress has been made in eluci-
dating the mechanism of CHS, the cellular and molecular
mechanisms regulating CHS are still obscure. CHS is
thought to be dependent on Th1 cells (2, 3, 20), although
IL-4 has also been demonstrated to be involved in the re-
sponse of CHS (7–9). It has also been reported that Th2
cells in mouse skin can induce a cellular inflammatory re-
sponse with faster kinetics (21). In this paper, we ques-
tioned whether Th2 cells or Th2-type cytokines were also
involved in the pathogenesis of the CHS response. It is well
known that Th2 cells or Th2-type cytokines inhibit the ac-
tivity of the Th1 cells in CHS in vitro. The IL-10 pro-
duced by Th2 cells indirectly inhibited the synthesis of
Th1-type cytokines by abrogating the secretion of IL-12 by
macrophages or by the secretion of Th1 cytokines (22, 23).
IL-4 directly inhibits Th1 cytokine, IL-12, and also inhib-
ited the effector phase of CHS (24). In contrast to these re-
ports, Asherson et al. (9) demonstrated that IL-4 plays a key
role in CHS. They speculated that the IL-4 secreted from
mast cells or B2201 cells binds to g/d1 T cells, and thus in-
duces them to produce IL-4 or different cytokines that in-
creased the expression of adhesion molecules on endothe-
lial cells, which play a critical role in the induction of CHS
(9). It has recently been reported that the CHS to DNFB
decreased in IL-4–deficient mice (10), in contrast with an-
other group’s results in which Oxa was used as a contact al-
lergen (11), and IL-4–deficient mice on a C57BL/6 did not
show a reduced ear swelling response 48 h after challenge
(11). A very recent report demonstrated that CHS to dini-
trochlorobenzene but not to Oxa is inhibited in IL-4–defi-
cient mice (12). It therefore remains unclear whether CHS
is upregulated or downregulated in IL-4–deficient mice.
Figure 8. (A) The cytokine levels in the supernatants from T cells acti-
vated with TNBS-modified spleen cells or nonmodified spleen cells in sen-
sitized STAT62/2 mice and wt (WT) mice. The lymph node cells were
prepared as described above. Single cell suspensions from lymph nodes
were purified for T cells by a nylon wool column. T cells were cultured in
the presence or absence of mitomycin C–treated TNBS-modified spleen
cells (TNP-SC) or nonmodified spleen cells (SC) for 3 d. The supernatants
were used for ELISA. No detectable IL-4 or IL-5 in supernatants from de-
ficient mice was observed. The data represent the mean concentrated val-
ues obtained from the supernatants from three wells and are representative
of three independent experiments. The bars depict mean cpm 1 SD for
triplicate experiments. *P , 0.01 compared with the cytokine levels in the
supernatants from T cells stimulated with nonmodified spleen cells. (B)
The cytokine levels in the skin tissue supernatants in olive oil– and
TNCB-challenged sensitized STAT62/2 mice and wt (WT) mice. The
data represent the mean 1 SD for groups of four mice and are representa-
tive of three independent experiments. The cytokine levels were measured
by comparing them with all other groups. *P , 0.01 compared with other
groups.
Figure 9. The population and function of LCs or Thy11 DEC T cells
between wt and STAT62/2 mice. (A) Thy11 DEC T cells and I-A1 LCs
show similar levels in the epidermal sheets prepared from STAT62/2
compared with wt (WT) mice. After epidermal sheets were prepared,
fixed, and washed with PBS, they were incubated overnight at 48C with
FITC-conjugated anti–I-A mAb or FITC-conjugated anti–TCR-g/d
mAb. The results shown are from a single experiment and are representa-
tive of three separate experiments. (B) The allostimulatory capacity of the
enriched LCs prepared from the STAT62/2 mice is similar to that from
the wt (WT) mice. ECs were prepared with trypsin from wt or STAT62/2
mice. The cultured LCs were harvested, separated with a gradient,
washed, and then used as stimulator cells for T cell proliferation. 105
CD31 T cells were seeded in the presence of 1–103 3 105 of enriched
LCs in 96-well round-bottomed culture plates. The proliferation of T
cells was revealed by [3H]TdR incorporation after 6 d of culturing. The
results are representative of five experiments. Bars depict mean cpm 1
SD for triplicate experiments.1002 STAT6 Signaling in Contact Hypersensitivity
We recently established STAT6-deficient mice and con-
cluded that STAT6 plays a central role in exerting IL-4–
and IL-13–mediated biological responses (13, 14). There-
fore, we used a STAT6-deficient mice model to study the
role of Th2 cytokines, especially IL-4 and IL-13, in CHS.
Compared with the wt control mice, the ear swelling re-
sponse in STAT62/2 mice significantly decreased at 24 h
after the challenge. However, the reduction in ear swelling
was not significant at 48 h after the challenge in the
TNCB-induced CHS. The peak response of ear swelling
was observed at 48 but not 24 h after challenge in
STAT62/2 mice sensitized with Oxa, TNCB, or DNFB as
the contact allergen. These data may be consistent with the
recent demonstration that IL-4 plays a major role in the
initiation phase of CHS and inhibits the late phase of CHS
(8, 9). However, our results do not correlate with those of
CHS in IL-42/2 mice, as the Oxa-induced CHS did not
diminish in the IL-42/2 mice (11, 12). It is well known
that the Th2 response was completely diminished in
STAT62/2 mice, but a residual Th2 response has been
clearly observed in IL-42/2 mice (13, 14). This may ex-
plain the marked differences of CHS in response to a hap-
ten challenge between the IL-42/2 mice and STAT62/2
mice.
Furthermore, neither the irritant response nor the DTH
response induced by sheep RBCs decreased in STAT62/2
mice. These results indicated that STAT6 signaling may
not play a critical role in the induction of either the irritant
response or the DTH response induced by sheep RBCs. In
contrast to IL-4 or IL-13, IL-10 is a suppressant of the cu-
taneous inflammatory response, including both the CHS
and the irritant response (11).
A histological analysis revealed a tremendous reduction
in the infiltration of both eosinophils and neutrophils in
TNCB-challenged skin of STAT62/2 mice. In addition,
the antigen-induced edematous changes in the dermis were
also completely dependent on STAT6 signaling. In mice,
the polymorphonuclear cell response has been demon-
strated to be more vigorous than in guinea pigs, and eosin-
ophils also infiltrated the TNCB-induced CHS in a peak
response at 24 h after challenge (25, 26). To date, the ex-
act roles of these polymorphonuclear cells are still un-
clear. However, our data indicate that polymorphonu-
clear cells, including eosinophils and neutrophils dependent
on STAT6 signaling, may play a major role in the induc-
tion of CHS.
Not only Th1 but also Th2 cells have been reported to
induce hapten-specific CHS (21), and STAT6 proteins
have been shown to be essential in Th2 differentiation in
vitro (13, 14). STAT6 signaling is essential for hapten-
induced increase in Th2 cytokine production in vivo. The
hapten-challenged wt mice demonstrated significant eleva-
tions in the Th2 cytokines (i.e., IL-4 and IL-5). In marked
contrast, STAT62/2 mice were unable to produce IL-4 or
IL-5 in response to the skin challenge. Interestingly, not
only in challenged skin but also in lymph nodes, no detect-
able Th2 cytokines in supernatants of T cells stimulated in a
hapten-specific manner were observed in STAT62/2 mice.
These data indicated that the Th2 cells defected in
STAT62/2 mice. A lack of Th2 cytokine production after
hapten challenge in STAT62/2 mice reflects the balance of
the Th1- and Th2-dependent antibody isotype production
in the serum of STAT62/2 mice. TNCB-challenged wt
mice developed an IgG1 and IgE antibody profile with a
low IgG2a level. In contrast, STAT62/2 mice have pre-
dominant IgG2 antibody production and no detectable
IgE, which is consistent with previous data in a mouse
model of atopic asthma (27–29). TNCB-challenged wt
mice produced a small amount of IgE. Ptak and colleagues
(18, 19) demonstrated that a low dose but not a high dose
of IgE mediated DTH initiation via release of small
amounts of 5-hydroxytryptamine by mast cells. IgE has also
been reported to induce late-phase cutaneous reactions in
humans (30, 31). These results indicate that a small amount
of IgE induced by STAT6 signaling in wt mice may play a
critical role in the induction of CHS.
Since IL-4 modulates the differentiation of LCs from
monocytes (32, 33), we examined the population, mor-
phology, surface marker, and function of LCs in STAT62/2
compared with wt mice. The density of LCs in the epi-
dermis of STAT62/2 mice did not decrease. After the
short-term culture of LCs, the development of LCs was not
impaired. The expression of costimulatory molecules on
LCs was not downregulated in STAT62/2 mice (data not
shown). In line with these data, the allostimulatory activity
of enriched LCs was also comparable in STAT62/2 and wt
mice. The fact that LCs differentiated normally in the ab-
sence of a passageway through Th2-derived cytokines cor-
relates with results by Weigmann et al. (10) and Georgopo-
ulos et al. (34). As far as the LCs are concerned, the
Figure 10. Lymph node cells from sensitized wt mice could induce
CHS in STAT62/2 mice. Adoptive transfer experiments were performed.
Lymph node cells from the sensitized wt mice were injected subcutane-
ously into the ears of STAT62/2 and wt mice. The mice were challenged
immediately after injection of lymph node cells with 1% TNCB or olive
oil. Ear swelling was measured after 24 h. As a negative control, mice
were challenged immediately after injection of PBS with 1% TNCB
(PBS). As a positive control, the mice were contact sensitized by two
daily consecutive topical applications of 50 ml of 5% TNCB on shaved
abdominal skin. After 5 d, these mice were challenged with 1% TNCB
(TNCB painting). The data represent the mean swelling values obtained
after 24 h with five mice per group and are representative of three inde-
pendent experiments. *P , 0.01 compared with other negative control
groups; **P , 0.05 compared with other negative control groups.1003 Yokozeki et al.
morphology, function, and surface marker of LCs in
STAT62/2 were comparable with those in the wt mice.
Interestingly, adoptive transfer experiments revealed that
the CHS response could be elicited when lymph node cells
from sensitized wt mice were injected into the ears of
STAT62/2 mice. These data indicate that STAT6 is an im-
portant signal during the induction phase, as also suggested
previously by recent reports (8, 12).
The transfer of DTH by cells from immune mice has
been shown to require collaboration between a/b- and
g/d-bearing T cells (35), and IL-4 plays a critical role
through g/d T cells (9). However, in contrast to IL-42/2
mice (10), density and morphology of g/d1 Thy1 dendritic
ECs (DECs) in the epidermis of the STAT62/2 mice were
comparable with those in wt mice. Further studies are pres-
ently being conducted to elucidate the exact role of g/d T
cells in CHS.
In summary, STAT6 is essential in the induction of
CHS. STAT6 mediates CHS via its pivotal role in Th2 dif-
ferentiation, resulting in the subsequent stimulation of IgE
synthesis and the infiltration of eosinophils or neutrophils
into the skin.
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